The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Type II Diabetes
Interventions
DRUG

PAZ320

Treatment arm B - 2 tablets of PAZ320 and 2 tablets of placebo, total of 4 tablets Treatment arm C - 4 tablets of PAZ320

OTHER

Placebo

Treatment arm A - 4 tablets of placebo Treatment arm B - 2 tablets of PAZ320 and 2 tablets of placebo, total of 4 tablets

Trial Locations (1)

14107

Department of Internal Medicine, Infectious Diseases and Diabetology Hopital Robert Bisson (Lisieux), Lisieux

Sponsors
All Listed Sponsors
lead

Boston Therapeutics

INDUSTRY